SCHEMBL6964221

SCHEMBL6964221

Cc1cc(-c2cc(O)c(SCCc3ccccc3)c(=O)o2)ccc1OCc1cccnc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 1/20 0.41
DRD2 P14416 1/20 0.41
MAOB P27338 2/20 0.39
MRGPRX4 Q96LA9 1/20 0.39
PRKDC P78527 2/20 0.38
LRRK2 Q5S007 3/20 0.37
PPARD Q03181 1/20 0.37
FFAR4 Q5NUL3 1/20 0.37
IKBKB O14920 1/20 0.37
P2RY12 Q9H244 1/20 0.37
NOS3 P29474 1/20 0.37
NOS1 P29475 1/20 0.37
NOS2 P35228 1/20 0.37
NOTUM Q6P988 1/20 0.37
PDE3B Q13370 1/20 0.37
PDE3A Q14432 1/20 0.37
CYP19A1 P11511 1/20 0.36
BCHE P06276 1/20 0.36
ACHE P22303 1/20 0.36
CYP11B1 P15538 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6964575 0.92 FFAR4 (0.44) MAOBMRGPRX4FFAR4BCHEACHE
SCHEMBL6959331 0.88 SYK (0.40) HTR1ADRD2MAOBMRGPRX4FFAR4
SCHEMBL6963290 0.86 TERT (0.43)
SCHEMBL6963073 0.84 PPARD (0.43) PPARD
SCHEMBL6959310 0.84 ABCB1 (0.43) MAOBMRGPRX4FFAR4BCHEACHE
SCHEMBL6959805 0.82 PTGS2 (0.46) MRGPRX4
SCHEMBL6957747 0.82 CYP1A1 (0.50) BCHEACHE
SCHEMBL6965249 0.81 HCAR2 (0.40)
SCHEMBL6964162 0.79 PDE3B (0.46) MAOBMRGPRX4PRKDCLRRK2P2RY12
SCHEMBL6965244 0.79 ALOX5 (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5808062-A AIDS THERAPY WARNER-LAMBERT COMPANY (US) 1998-09-15 US claimed
EP-0729466-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP claimed
WO-1995014014-A2 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO claimed
EP-0729465-B1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE DAVIS & CO (US) 2003-01-22 EP disclosed
US-6005103-A TREATMENT OF BACTERIAL AND VIRAL INFECTIONS AND DISEASES, INCLUDING AIDS WARNER-LAMBERT COMPANY (US) 1999-12-21 US disclosed
US-5808062-A AIDS THERAPY WARNER-LAMBERT COMPANY (US) 1998-09-15 US disclosed
EP-0729465-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP disclosed
EP-0729466-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP disclosed
WO-1995014013-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO disclosed
WO-1995014014-A2 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO disclosed